Gynecology

Yes, when the medical record supports a link. The link can be direct (the condition began in service, or an in-service injury or disease caused it), secondary (another service-connected condition caused or worsened it, under 38 CFR 3.310), or aggravation (a condition that existed before service got worse during service beyond its natural progress, under 38 CFR 3.306). A gynecology nexus letter explains the medical connection. The VA decides the claim.

Often, yes. An entry for cramps or heavy bleeding shows that symptoms existed in service. It does not say that those symptoms were the early course of the endometriosis, fibroids, or adenomyosis diagnosed later. That link is a clinical judgment, and it has to be written down by a physician who has read the whole record. If your condition was diagnosed and treated in service and the record is clear, a letter may add little, and we will tell you so.

Endometriosis has its own code, DC 7629, under 38 CFR 4.116. It is rated 10 percent for pelvic pain or heavy or irregular bleeding requiring continuous treatment for control, and 30 percent when those symptoms are not controlled by treatment. The 50 percent level requires lesions involving bowel or bladder confirmed by laparoscopy, together with pelvic pain or heavy or irregular bleeding not controlled by treatment, and bowel or bladder symptoms. A note under the code says the diagnosis must be substantiated by laparoscopy.

This is a real gap between the VA rule and current medicine. The 38 CFR 4.116 note under DC 7629 still says the diagnosis must be substantiated by laparoscopy. The 2022 ESHRE endometriosis guideline recommends imaging (ultrasound or MRI) in the diagnostic work-up and recommends that clinicians consider offering laparoscopy when imaging is negative or when empirical treatment was unsuccessful or inappropriate. The guideline says this approach challenges laparoscopy as the gold standard test. It also notes that a negative scan does not rule endometriosis out. A physician opinion can explain how your diagnosis was made and why it is reliable, but it cannot change the wording of the regulation. The VA decides how to apply it. On October 1, 2025, VA proposed removing the note (90 FR 47266), which would allow ratings up to 30 percent without laparoscopy while keeping the laparoscopy requirement at 50 percent. It is proposed, not final, as of October 2026.

Under 38 CFR 4.116, removal of the uterus including the corpus (DC 7618) is rated 100 percent for three months after removal and 30 percent thereafter. Removal of the uterus and both ovaries (DC 7617) is rated 100 percent for three months and 50 percent thereafter. The hysterectomy itself generally needs to be service connected, for example as secondary to a service-connected condition under 38 CFR 3.310, or because it treated a disease that began in service. Removal of one ovary (DC 7619) is rated 0 percent after the first three months, but a note under that code assigns 30 percent when one ovary was removed because of a service-connected injury or disease and the second ovary is absent or nonfunctioning for a reason unrelated to service.

Both are flagged for review. In the 38 CFR 4.116 rating table, every rating line for removal of the uterus and both ovaries (DC 7617), removal of the uterus (DC 7618), removal of an ovary (DC 7619), and complete atrophy of both ovaries (DC 7620) carries a footnote directing review for special monthly compensation under 38 CFR 3.350. Note 2 to the section gives the same instruction for any claim involving loss or loss of use of a creative organ. Section 3.350 says the benefit may be granted when a creative organ was lost through operations in service for the relief of other conditions, the organ becoming incidentally involved. It also says loss traceable to an elective operation performed after service does not establish entitlement, unless that operation was required to correct a specific injury caused by an earlier operation in service. The same section says an operation is not considered elective when it is advised on sound medical judgment for the relief of a pathological condition or to prevent possible future pathological consequences. The VA makes the SMC decision.

Research shows an association. A national study of more than 71,000 OEF/OIF women veterans who used VA health care found that women with PTSD had higher odds of diagnoses such as PCOS, endometriosis, painful periods, and female genital pain, and the risk was highest in women with both PTSD and depression. That study looked at PTSD and depression diagnoses, not military sexual trauma itself, and it shows association, not proof of cause. A secondary-claim opinion has to explain a plausible mechanism for your condition and address other explanations, rather than lean on the statistic alone.

Possibly. A meta-analysis found SSRIs and the SNRI venlafaxine associated with more sexual dysfunction than placebo. A federal (AHRQ) review found some of these drugs linked to more reports of decreased vaginal lubrication in women than other antidepressants. The VA rates female sexual arousal disorder under DC 7632 at 0 percent, with a footnote directing review for special monthly compensation under 38 CFR 3.350. A secondary opinion would connect the arousal disorder to the medication prescribed for the service-connected condition and address other possible causes.

PCOS can be service connected, but it has no diagnostic code of its own in 38 CFR 4.116. A note to the General Rating Formula says disease of the ovaries resulting in ovarian dysfunction affecting the menstrual cycle, such as dysmenorrhea and secondary amenorrhea, is rated under DC 7615. A condition without its own code may also be rated by analogy under 38 CFR 4.20, using a closely related condition. Which code applies is the VA's decision. An international process has renamed PCOS polyendocrine metabolic ovarian syndrome (PMOS), and the VA rating schedule does not list it under either name. The 2023 international PCOS guideline reports a high prevalence of depression and anxiety in PCOS, a significantly higher prevalence of obstructive sleep apnea than in women without PCOS, and an increased risk of type 2 diabetes. That is why a PCOS opinion may also address secondary conditions.

Infertility has no diagnostic code of its own in 38 CFR 4.116, so the opinion focuses on the condition causing it, such as endometriosis, PCOS, or the loss of an ovary, and how that condition connects to service. A condition without its own code may be rated by analogy under 38 CFR 4.20. For Camp Lejeune, female infertility is among the conditions covered for VA health care and the Family Member Program, but it is not one of VA's presumptive conditions for disability compensation.

No. Note 1 to 38 CFR 4.116 says natural menopause, primary amenorrhea, and pregnancy and childbirth are not disabilities for rating purposes. The same note says chronic residuals of medical or surgical complications of pregnancy may be. Pelvic organ prolapse due to injury, disease, or surgical complications of pregnancy has its own code, DC 7621, rated 10 percent, with any genitourinary, digestive, or skin symptoms evaluated separately and combined.

Yes, but not as a separate anemia rating. A note in 38 CFR 4.117 says iron deficiency anemia due to blood loss is not evaluated under DC 7720. It is evaluated under the criteria for the condition causing the blood loss. Heavy menstrual bleeding from fibroids or endometriosis can cause iron deficiency anemia, so the opinion should document the bleeding, the lab results, and the treatment.

Under the PACT Act, VA lists reproductive cancer of any type as presumptive for veterans who served in covered locations, which include Iraq, Kuwait, Saudi Arabia, and other listed countries on or after August 2, 1990, and Afghanistan, Djibouti, Syria, and other listed countries on or after September 11, 2001. When the presumption applies, VA presumes the link to service, so a physician opinion is more likely to help with treatment residuals, such as surgical loss of the uterus or ovaries. Cancer claims are covered on our Oncology hub.

A board-certified OB/GYN, starting at $1,800+, fits endometriosis, fibroids, hysterectomy and ovary removal, pelvic organ prolapse, female sexual arousal disorder, and residuals of pregnancy complications. A board-certified reproductive endocrinologist, starting at $2,500+, fits PCOS, infertility, ovarian failure, and atrophy of the ovaries, where the questions are hormonal. Both prices include every supported claim theory in one letter and a consultation with the physician. We will recommend the less expensive specialist when the medical question allows it.

It is a no-obligation conversation about your gynecologic history, your service records, and what you are claiming. We talk through which pathway fits: direct, secondary, aggravation, or a residual of a service-connected surgery. Then we tell you whether a physician opinion would add anything. Bring your rating decision, any C&P exam report, and operative or pathology reports if you have them. If a letter would not help, we will say so.